Renal outcomes in mixed proliferative and membranous lupus nephritis (Class III/IV + V): A long-term observational study

Mod Rheumatol. 2016 Nov;26(6):908-913. doi: 10.3109/14397595.2016.1158896. Epub 2016 Apr 26.

Abstract

Objectives: In this study, we aimed to assess the effect of combination of proliferative and membranous lesions (Class III + V or IV + V) on renal outcomes as an independent category distinct from Class III and IV.

Methods: We retrospectively analyzed 103 Japanese patients (14 male and 89 female) with Class III/IV LN, with or without Class V, who underwent renal biopsy and were treated at our institution. Renal endpoint was defined as doubling of serum creatinine or end-stage renal disease (ESRD).

Results: The number of patients in each group was as follows: pure Class III/IV, 81 patients and mixed Class III/IV + V, 22 patients. During a median follow-up period of 125.0 months, 10 patients developed renal endpoint: five had Class III/IV LN and five had a combination of Class III/IV + V. Kaplan-Meier analyses demonstrated that patients with mixed Class III/IV + V LN had significantly poorer renal outcomes than patients with Class III/IV LN. Multivariate Cox regression analyses identified serum creatinine, active and chronic lesions (A/C), and mixed Class III/IV + V) as independent risk factors for poor renal outcomes.

Conclusions: This study demonstrated a combination of proliferative and membranous LN (ISN/RPS Class III/IV + V) predicts poor renal outcomes.

Keywords: ISN/RPS classification; Lupus nephritis; Renal outcome; Systemic lupus erythematosus.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Female
  • Humans
  • Kidney / pathology*
  • Lupus Nephritis / pathology*
  • Male
  • Middle Aged